These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1094965)

  • 1. Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.
    Fletcher MR; Loebl W; Scott JT
    Ann Rheum Dis; 1975 Apr; 34(2):190-4. PubMed ID: 1094965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal blood loss on phenylbutazone and feprazone.
    Macfarlane JD; Maisey MN; Grahame R; Burry HC
    Rheumatol Rehabil; 1976 May; 15(2):108-11. PubMed ID: 132693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some studies of feprazone.
    Haslock I; Burkinshaw L; Berry DJ; Donovan B; Wright V
    Rheumatol Rehabil; 1976 May; 15(2):81-6. PubMed ID: 132695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feprazone compared with indomethacin in the management of rheumatoid arthritis.
    Sturrock R; Isaacs A; Hart FD
    Practitioner; 1975 Jul; 215(1285):94-7. PubMed ID: 1103113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind trial of feprazone and phenylbutazone in acute gout.
    Reardon JA; Stockman A; Darlington LG; Scott JT
    Curr Med Res Opin; 1980; 6(7):445-8. PubMed ID: 6988172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind trial of feprazone in osteoarthritis of the hip.
    Bain LS; Lynch MP; Bruce GM
    Curr Med Res Opin; 1977; 4(9):665-9. PubMed ID: 338255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trial of feprazone in ankylosing spondylitis.
    Harkness AJ; Burry HC; Grahame R
    Rheumatol Rehabil; 1977 Aug; 16(3):158-61. PubMed ID: 333540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of an open study and a controlled comparative study of feprazone and naproxen in patients with rheumatoid arthritis or osteoarthrosis (author's transl)].
    Crone M; Geimer R
    Wien Med Wochenschr; 1981 Dec; 131(23-24):597-601. PubMed ID: 7039147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monitored-release study of methrazone in general practice.
    Harris PG
    J Int Med Res; 1980; 8(4):276-82. PubMed ID: 6447635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of feprazone for long-term treatment of rheumatoid arthritis and osteoarthritis.
    Bianchi G; Cerri B; Grasso S; Carazzi R; Dotti F; Ongari R; Cerrato O; Viara M
    Clin Ther; 1981; 3(5):349-55. PubMed ID: 7471130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind trial to assess the value of alclofenac compared with phenylbutazone in the management of rheumatoid arthritis.
    Chamberlain MA; Wright V
    Ann Rheum Dis; 1975 Apr; 34(2):186-9. PubMed ID: 237493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of feprazone in rheumatoid arthritis (author's transl)].
    Shichikawa K; Maeda A; Iwasaki Y
    Ryumachi; 1979 Apr; 19(2):147-63. PubMed ID: 375431
    [No Abstract]   [Full Text] [Related]  

  • 13. Ibuprofen or aspirin in rheumatoid arthritis therapy.
    Blechman WJ; Schmid FR; April PA; Wilson CH; Brooks CD
    JAMA; 1975 Jul; 233(4):336-40. PubMed ID: 1095794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miscellaneous rheumatological conditions treated in monitored-release studies with feprazone.
    Harris PG
    J Int Med Res; 1981; 9(4):248-52. PubMed ID: 6973494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on a new acetylsalicylic acid/paracetamol preparation with gastric acid resistant coating (Safapryn), and on two various phenylbutazone dosages in patients with primary chronic polyarthritis as based on a new evaluation method].
    Brooks PM; Walker JJ; Lee P; Bell AM; Buchanan WW; Fowler PD; Anderson JA
    Z Rheumatol; 1975; 34(9-10):350-65. PubMed ID: 1106038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing effect of feprazone on hepatic drug-metabolizing enzymes in man.
    Morita K; Shibata H; Ono T; Shimakawa H
    Eur J Clin Pharmacol; 1986; 31(1):117-8. PubMed ID: 3780819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of thermography in the evaluation of the anti-inflammatory activity of feprazone on rheumatoid arthritis.
    Singer F; Gruber J; Graber J; Reinthaler M; Thumb N
    Arzneimittelforschung; 1982; 32(4):427-9. PubMed ID: 7201815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis. Results of a multi-centre, double-blind, cross-over trial against phenylbutazone.
    Sydnes O; Brath HK; Haerum LB; Straume S
    Scand J Rheumatol Suppl; 1976; 1976(0):119-22. PubMed ID: 790547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
    Mizushima Y; Shiokawa Y; Honma M; Kageyama T
    Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.
    Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW
    Ann Rheum Dis; 1975 Oct; 34(5):416-21. PubMed ID: 769707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.